Clinical Trial Update: UARK 2005-05, Coagulation-Related Effects of Velcade Treatment in Patients With Relapsed or Refractory Multiple Myeloma [NA]

View source ↗

Summary

A completed clinical trial evaluating coagulation-related effects of Velcade (bortezomib) in relapsed or refractory multiple myeloma; results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: University of Arkansas | Conditions: MULTIPLE MYELOMA | NA | Status: COMPLETED | Results posted: 2011-08-12